Skip to content

Clareon™ CNWTT3 (UDI 00380652468763)Recalls & reported problems

Alcon Laboratories, Inc. · STERILE UV and Blue Light Filtering Hydrophobic Acrylic Foldable Diffractive Aspheric Toric Posterior Chamber Intraocular Lens · Class 3 · Implant

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00380652468763), received between Apr 6, 2026 and Jul 14, 2026 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Failure to Deliver” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 1 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 1 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Failure to Deliver1
  • Particulates1

Patient problems

  • Blurred Vision1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 14, 2026Particulates

    A NON-HEALTHCARE PROFESSIONAL REPORTED AFTER ONE TO TWO WEEKS OF CATARACT AND INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED SMALL SPOTS AND BLURRED VISION IN BOTH EYES AND WAS HOSPITALIZED. NO INFLAMMATION WAS OBSERVED, AND THE SURGEON SUSPECTED THAT THE CAUSE MAY BE RELATED TO THE LENS OR THE VISCOELASTIC. THE PATIENT¿S CURRENT CONDITION WAS NOT REPORTED. THE SURGEON REPORTED THAT THE COLD CHAIN WAS PROBABLY NO LONGER IN OPTIMAL CONDITION AND IT WAS NOT POSSIBLE TO DETECT THE PROBLEM BEFORE USING THE PRODUCT, AND THE PROCEDURE WAS COMPLETED ON THE SAME DAY WITHOUT DELAY. THERE WERE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS PATIENT, AND THIS REPORT WAS ASSOCIATED WITH THE RIGHT EYE. ADDITIONAL INFORMATION WAS REQUESTED BUT WAS NOT AVAILABLE AT THE TIME OF THIS REPORT.

    Patient problems: Blurred Vision

    MAUDE report 25810528 ↗
  • MalfunctionApr 6, 2026Failure to Deliver

    A HEALTH CARE PROFESSIONAL REPORTED THAT DURING SURGERY THE PLUNGER WENT OVER THE INTRAOCULAR LENS (IOL) AND DID NOT INJECT IT. THE SURGEON THUS SWITCHED OVER TO A DIFFERENT INJECTOR (COMPANY PROVIDED INJECTOR) AND AN UNSPECIFIED LENS TO COMPLETE THE SURGERY. THERE WAS NO PATIENT HARM.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24791493 ↗

Other LENS, INTRAOCULAR, TORIC OPTICS devices

All LENS, INTRAOCULAR, TORIC OPTICS devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.